Filtros de búsqueda

Lista de obras de

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

artículo científico publicado en 2015

A new combination for advanced multiple myeloma

artículo científico publicado en 2011

An European Myeloma Network recommendation on tools for diagnosis and monitoring of multiple myeloma: what to use and when

scholarly article by Jo Caers et al published 31 August 2018 in Haematologica

Autologous Transplantation in Elderly Multiple Myeloma Patients: Is the Procedure Cost Effective?

artículo científico publicado en 2015

Autologous transplant for myeloma: when the old meets the new.

artículo científico publicado en 2017

Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.

artículo científico publicado en 2016

Autologous transplantation and maintenance therapy in multiple myeloma

artículo científico publicado en 2014

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

artículo científico publicado en 2013

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.

artículo científico publicado en 2008

CD38 As an Immunotherapeutic Target in Multiple Myeloma

artículo científico publicado en 2018

Cardiovascular adverse events in modern myeloma therapy - incidence and risks. A review from European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

article

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

artículo científico publicado en 2015

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

artículo científico publicado en 2014

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

artículo científico publicado en 2010

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.

artículo científico publicado en 2015

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

scientific article published on 14 April 2020

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

artículo científico publicado en 2011

Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma.

artículo científico publicado en 2015

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

scientific article published on 14 September 2018

Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma.

artículo científico publicado en 2014

CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab

scientific article published on 25 March 2019

Do we need cytogenetics in the follow-up of multiple myeloma?

artículo científico publicado en 2019

Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.

artículo científico publicado en 2011

Efficacy and safety of bortezomib in patients with plasma cell leukemia

artículo científico publicado en 2007

Emerging drugs and combinations to treat multiple myeloma

artículo científico publicado en 2017

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

artículo científico publicado en 2019

European Myeloma Network guidelines for the management of multiple myeloma-related complications

artículo científico publicado en 2015

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

artículo científico publicado en 2014

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

artículo científico publicado en 2018

Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy

artículo científico publicado en 2018

Evaluation of the pharmacokinetics, preclinical, and clinical efficacy of lenalidomide for the treatment of multiple myeloma

artículo científico publicado en 2012

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

artículo científico publicado en 2018

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

scientific article published on February 2014

How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.

scientific article published on January 2009

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

artículo científico

Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors

artículo científico publicado en 2017

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?

artículo científico publicado en 2017

Insights into defibrotide: an updated review.

artículo científico publicado en 2009

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma

scientific article published on 01 May 2006

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

artículo científico publicado en 2017

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

artículo científico publicado en 2017

Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials.

artículo científico publicado en 2016

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

artículo científico publicado en 2009

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma

artículo científico publicado en 2010

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients

scientific article published on 21 September 2012

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

artículo científico publicado en 2009

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

artículo científico publicado en 2014

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

artículo científico publicado en 2018

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis

scientific article published on 19 April 2018

Management of disease- and treatment-related complications in patients with multiple myeloma.

artículo científico publicado en 2010

Management of myeloma: an Italian perspective

artículo científico publicado en 2011

Management of older patients with multiple myeloma.

artículo científico publicado en 2011

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

scientific article published on 22 May 2020

Melphalan and its role in the management of patients with multiple myeloma.

artículo científico publicado en 2007

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

artículo científico publicado en 2010

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

scientific article published on 13 October 2016

Monoclonal antibodies currently in Phase II and III trials for multiple myeloma.

artículo científico

Novel investigational drugs active as single agents in multiple myeloma.

artículo científico publicado en 2017

Nuances in the Management of Older People With Multiple Myeloma

artículo científico publicado en 2016

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

artículo científico publicado en 2008

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma.

artículo científico

Plasma cell leukemia: update on biology and therapy.

artículo científico publicado en 2016

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

artículo científico publicado en 2018

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

scientific article published on 08 April 2019

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients

artículo científico publicado en 2011

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma

artículo científico publicado en 2018

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies

scientific article published on 13 December 2019

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

artículo científico publicado en 2020

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

artículo científico publicado en 2015

Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma.

artículo científico publicado en 2016

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

artículo científico publicado en 2022

Special problems in the management of elderly patients with multiple myeloma

artículo científico publicado en 2018

Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2020

Stem Cell Transplantation in Multiple Myeloma.

artículo científico publicado en 2016

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

artículo científico publicado en 2014

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

artículo científico publicado en 2010

The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents

artículo científico

Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.

artículo científico publicado en 2007

Towards a new standard of care for patients with myeloma?

artículo científico publicado en 2009

Treatment of Newly Diagnosed Elderly Multiple Myeloma.

artículo científico publicado en 2016

Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda